A trend analysis of the prevalence, awareness, treatment, and control of hypertension by age group

Journal of Preventive Medicine and Public Health

Volumn 46, Issue 6, 2013, Pages 353-359

  Moon, Jong Youn ^a   Park, Kwan Jun ^a   Hwangbo, Young ^a   Lee, Mee Ri ^a   Yoo, Byoung In ^a   Won, Jong Hye ^a   Park, Yoon Hyung ^a  

^a Soonchunhyang University   (South Korea)

Author keywords

Awareness; Hypertension; Korean National Health and Nutrition Examination Survey; Prevalence; Prevention control; Therapeutics

Indexed keywords

ADULT; ARTICLE; AWARENESS; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HEALTH CARE POLICY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MIDDLE AGED; PREVALENCE;

AWARENESS; HYPERTENSION; KOREAN NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY; PREVALENCE; PREVENTION & CONTROL; THERAPEUTICS;

ADULT; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERTENSION; LINEAR MODELS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; SEX FACTORS; THERAPEUTICS;

EID: 84892695332     PISSN: 19758375     EISSN: None     Source Type: Journal    
DOI: 10.3961/jpmph.2013.46.6.353     Document Type: Article

References (21)

1. World Health Organization. The global burden of disease. Geneva: World Health Organization; 2008, p. 25-26.
2. Chung HG, Kang YK. 2009 National health insurance statistical yearbook. Seoul: National Health Insurance Corporation; 2010, p. 351-598.
3. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001;345(18):1291-1297.
4. Khosla N, Kalaitzidis R, Bakris GL. The kidney, hypertension, and remaining challenges. Med Clin North Am 2009;93(3):697-715.
5. Wong ND, Thakral G, Franklin SS, L'Italien GJ, Jacobs MJ, Whyte JL, et al. Preventing heart disease by controlling hypertension: impact of hypertensive subtype, stage, age, and sex. Am Heart J 2003;145(5):888-895.
6. Statistics Korea. Mortality statistics 2011 [cited 2013 Sep 23]. Available from: http://kostat.go.kr/portal/korea/kor-nw/2/6/2/index.board?bmode= read&aSeq=260046.
7. Epping-Jordan J. Innovate care for chronic conditions: building blocks for action global report. Geneva: World Health Organization; 2002, p. 12-13.
8. Alleyne G, Binagwaho A, Haines A, Jahan S, Nugent R, Rojhani A, et al. Embedding non-communicable diseases in the post-2015 development agenda. Lancet 2013;381(9866):566-574.
9. World Health Organization. NCD global monitoring framework [cited 2013 Sep 23]. Available from: http://www.who.int/nmh/global-monitoring-framework/en/.
10. Chobanian AV. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda: National Institutes of Health; National Heart, Lung, and Blood Institute; 2004, p. 9-10.
11. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, et al. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004;43(1):10-17.
12. Rashid P, Leonardi-Bee J, Bath P. Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34(11):2741-2748.
13. Fortmann SP, Winkleby MA, Flora JA, Haskell WL, Taylor CB. Effect of long-term community health education on blood pressure and hypertension control. The Stanford Five-City Project. Am J Epidemiol 1990;132(4):629-646.
14. Kotchen JM, McKean HE, Jackson-Thayer S, Moore RW, Straus R, Kotchen TA. Impact of a rural high blood pressure control program on hypertension control and cardiovascular disease mortality. JAMA 1986;255(16):2177-2182.
15. Iso H, Shimamoto T, Naito Y, Sato S, Kitamura A, Iida M, et al. Effects of a long-term hypertension control program on stroke incidence and prevalence in a rural community in northeastern Japan. Stroke 1998;29(8):1510-1518.
16. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010;303(20):2043-2050.
17. Guo F, He D, Zhang W, Walton RG. Trends in prevalence, awareness, management, and control of hypertension among United States adults, 1999 to 2010. J Am Coll Cardiol 2012;60(7):599-606.
18. Lee WY, Park JS, Noh SY, Rhee EJ, Kim SW, Zimmet PZ. Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects. Diabetes Res Clin Pract 2004;65(2):143-149.
19. Ha YC, Chun HJ, Hwang HK, Kim BS, Kim Jr. The prevalence, awareness, treatment, and control of hypertension, and related factors in rural Korea. Korean J Prev Med 2000;33(4):513-520 (Korean).
20. Gu D, Reynolds K, Wu X, Chen J, Duan X, Muntner P, et al. The International Collaborative Study of Cardiovascular Disease in ASIA. Prevalence, awareness, treatment, and control of hypertension in china. Hypertension 2002;40(6):920-927.
21. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008;51(6):1403-1419.